Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Asthma outcomes: biomarkers.

Szefler SJ, Wenzel S, Brown R, Erzurum SC, Fahy JV, Hamilton RG, Hunt JF, Kita H, Liu AH, Panettieri RA Jr, Schleimer RP, Minnicozzi M.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S9-23. doi: 10.1016/j.jaci.2011.12.979. Review.

2.

Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum.

Crespo A, Giner J, Torrejón M, Belda A, Mateus E, Granel C, Torrego A, Ramos-Barbón D, Plaza V.

J Asthma. 2016 Jun;53(5):459-64. doi: 10.3109/02770903.2015.1116086. Epub 2016 Jan 19.

PMID:
26785727
3.

Biomarkers in asthma.

Murugan A, Prys-Picard C, Calhoun WJ.

Curr Opin Pulm Med. 2009 Jan;15(1):12-8. doi: 10.1097/MCP.0b013e32831de235. Review.

PMID:
19077700
4.

Recent advances in asthma biomarker research.

Leung TF, Ko FW, Wong GW.

Ther Adv Respir Dis. 2013 Oct;7(5):297-308. doi: 10.1177/1753465813496863. Epub 2013 Aug 1. Review.

PMID:
23907809
5.

Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophils and leukotriene E4.

Gogate S, Katial R.

Curr Opin Allergy Clin Immunol. 2008 Apr;8(2):154-7. doi: 10.1097/ACI.0b013e3282f60f61. Review.

PMID:
18317025
6.

Exhaled nitric oxide following leukotriene E(4) and methacholine inhalation in patients with asthma.

Deykin A, Belostotsky O, Hong C, Massaro AF, Lilly CM, Israel E.

Am J Respir Crit Care Med. 2000 Nov;162(5):1685-9.

PMID:
11069797
7.

Asthma outcomes workshop: overview.

Busse WW, Morgan WJ, Taggart V, Togias A.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S1-8. doi: 10.1016/j.jaci.2011.12.985.

8.

Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.

Liu T, Wu J, Zhao J, Wang J, Zhang Y, Liu L, Cao L, Liu Y, Dong L.

Respir Med. 2015 Nov;109(11):1391-6. doi: 10.1016/j.rmed.2015.09.016. Epub 2015 Oct 9.

9.

Asthma outcomes: pulmonary physiology.

Tepper RS, Wise RS, Covar R, Irvin CG, Kercsmar CM, Kraft M, Liu MC, O'Connor GT, Peters SP, Sorkness R, Togias A.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S65-87. doi: 10.1016/j.jaci.2011.12.986. Review.

10.

Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers.

Hillas G, Kostikas K, Mantzouranis K, Bessa V, Kontogianni K, Papadaki G, Papiris S, Alchanatis M, Loukides S, Bakakos P.

Respirology. 2011 Jul;16(5):811-8. doi: 10.1111/j.1440-1843.2011.01984.x.

PMID:
21545371
11.

Allergen exposure modifies the relation of sensitization to fraction of exhaled nitric oxide levels in children at risk for allergy and asthma.

Sordillo JE, Webb T, Kwan D, Kamel J, Hoffman E, Milton DK, Gold DR.

J Allergy Clin Immunol. 2011 May;127(5):1165-72.e5. doi: 10.1016/j.jaci.2011.01.066. Epub 2011 Apr 3.

12.

Asthma outcomes: exacerbations.

Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo CA Jr, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, Blaisdell C.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S34-48. doi: 10.1016/j.jaci.2011.12.983. Review.

13.

Asthma, atopy and exhaled nitric oxide in a cohort of 6-yr-old New Zealand children.

Crane J, Lampshire P, Wickens K, Epton M, Siebers R, Ingham T, Pattemore P, Town I; Year Six New Zealand Asthma and Allergy Cohort Study Group (NZAACS6).

Pediatr Allergy Immunol. 2012 Feb;23(1):59-64. doi: 10.1111/j.1399-3038.2011.01227.x. Epub 2011 Nov 22.

PMID:
22104032
14.

Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma.

Tseliou E, Bessa V, Hillas G, Delimpoura V, Papadaki G, Roussos C, Papiris S, Bakakos P, Loukides S.

Chest. 2010 Jul;138(1):107-13. doi: 10.1378/chest.09-1257. Epub 2010 Feb 19.

PMID:
20173051
15.

Both exhaled nitric oxide and blood eosinophil count were associated with mild allergic asthma only in non-smokers.

Giovannelli J, Chérot-Kornobis N, Hulo S, Ciuchete A, Clément G, Amouyel P, Matran R, Dauchet L.

Clin Exp Allergy. 2016 Apr;46(4):543-54. doi: 10.1111/cea.12669.

PMID:
26542195
16.

[Determining asthma treatment in children by monitoring fractional exhaled nitric oxide, sputum eosinophils and leukotriene B₄].

Vizmanos-Lamotte G, Cruz MJ, Gómez-Ollés S, Muñoz X, de Mir Messa I, Moreno-Galdó A.

An Pediatr (Barc). 2015 Jan;82(1):e21-5. doi: 10.1016/j.anpedi.2014.03.012. Epub 2014 May 22. Spanish.

17.

Cutoff point for exhaled nitric oxide corresponding to 3% sputum eosinophils.

Alvarez-Puebla MJ, Olaguibel Rivera JM, Almudevar E, Echegoyen AA, de Esteban Chocarro B, Cambra K.

J Investig Allergol Clin Immunol. 2015;25(2):107-11.

18.

Usefulness of noninvasive methods for the study of bronchial inflammation in the control of patients with asthma.

Muñoz X, Bustamante V, Lopez-Campos JL, Cruz MJ, Barreiro E.

Int Arch Allergy Immunol. 2015;166(1):1-12. doi: 10.1159/000371849. Epub 2015 Feb 27. Review.

PMID:
25765083
19.

Exhaled nitric oxide is associated with allergic inflammation in children.

Choi BS, Kim KW, Lee YJ, Baek J, Park HB, Kim YH, Sohn MH, Kim KE.

J Korean Med Sci. 2011 Oct;26(10):1265-9. doi: 10.3346/jkms.2011.26.10.1265. Epub 2011 Oct 1.

20.

Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study.

Scott M, Raza A, Karmaus W, Mitchell F, Grundy J, Kurukulaaratchy RJ, Arshad SH, Roberts G.

Thorax. 2010 Mar;65(3):258-62. doi: 10.1136/thx.2009.125443.

Supplemental Content

Support Center